Therapeutic Apheresis Toll Free Contact:
(866) 956-NYBC (6922) E-mail Contact:
NYBCTAS@NYBloodCenter.org
Clinical Apheresis Services
Clinical Apheresis is the removal of abnormal or pathologic substances from a patient's blood using an automated blood cell separator machine. A replacement fluid such as fresh frozen plasma, human serum albumin or normal saline is often required.
NYBC brings the mobile Therapeutic Apheresis Services directly to the patient's facility, providing the latest continuous-flow apheresis technology operated by skilled therapeutic apheresis nurse-specialists. NYBC also follows the standards and procedures set by the American Association of Blood Banks (AABB) and the American Society for Apheresis (ASFA).
Different Types and Uses of Clinical Apheresis
Plasmapheresis: Therapeutic plasma exchange
Leukapheresis: Therapeutic white cell depletion
Erythrocytapheresis: Therapeutic red cell removal and exchange
Plateletpheresis: Platelet depletion
Immunoadsorption: Removal of IgG and plasma- circulating immune complexes
Our service has been carefully designed to provide the following benefits: - No need to transfer patients: Our mobile service comes to the patient's hospital, eliminating the need to transfer patients elsewhere for clinical apheresis services
- Specialized Registered Nurses trained in apheresis
- Unlimited access to NYBC staff physicians: Our physicians are recognized transfusion medicine specialists and are available to support the course of treatment and answer questions regarding patient management
- SOP-directed practice
- Quality assurance of all equipment
- Low extracorporeal volumes improves patient safety by reducing potential reactions; the reduced volume is especially beneficial for pediatric patients
- Consistent fluid balance and precise component separation through computerized calibration: Effective for all patients, regardless of age and weight
- Shorter run times enhance patient comfort
- On-Demand service
Clinical Apheresis Immunoadsorption Column
In an immunoadsorption treatment, patient plasma is collected by apheresis and passed through a column containing protein A, which binds IgG and immune complexes. The plasma is then returned to the patient. Protein A immunoadsorption column treatment is used in immune thrombocytopenia, and hemolytic uremic syndrome (HUS).
A typical course of treatment is generally 6-12 procedures. This will vary with the clinical status of the patient. The procedure benefits the patient by the removal of potentially harmful blood constituents and subsequent immune modulation.
| 
